LEUCEMIE AIGUE PDF

La leucémie aiguë mégacaryoblastique, ou de type 7 (LAM7), représente 0,5 à 2 % des leucémies aiguës (LA) de l’enfant et 3 à 10 % des leucémies aiguës. Aspects épidémiologiques, cliniques, cytologiques et immunophénotypiques des leucémies aiguës chez les enfants: expérience du laboratoire d’hématologie. Disease definition. Acute myeloid leukemia (AML) is a group of neoplasms arising from precursor cells committed to the myeloid cell-line differentiation.

Author: Gubar Akinozshura
Country: Rwanda
Language: English (Spanish)
Genre: Politics
Published (Last): 21 May 2006
Pages: 322
PDF File Size: 13.71 Mb
ePub File Size: 5.38 Mb
ISBN: 879-4-12149-511-8
Downloads: 17991
Price: Free* [*Free Regsitration Required]
Uploader: Guramar

Leucémie myéloïde aiguë

Differential diagnosis includes megaloblastic anaemia, leucemie aigue syndromes, acute lymphoblastic leukemia, acute biphenotypic leukemia, chronic myeloid leukemia myeloid blast phaseand metastases of tumors such rhabdomyosarcoma and neuroblastoma see these terms. Class I mutations qigue in proliferative advantage while the class II mutations alter the leucemie aigue hematopoietic differentiation.

Additional information Further information on this disease Classification s 2 Gene s 34 Other leucemie aigue s 2.

Journal page Archives Contents list. Other search iague s Alphabetical list.

Bone and joint manifestations in a 7-month-old child. Refractory or relapsed AML is treated with a second leucemie aigue course adding new drugs such gemtuzumab ozogamicin to the standard treatment.

Diagnosis relies on laboratory findings showing anemia, thrombocytopenia and leucopenia or leukocytosis which result from disturbed hematopoietic function due to bone marrow and peripheral blood infiltration by immature leucemie aigue cells. Only comments written in Aigur can be processed. We had a variety of indirect evidence for our assumption: Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted.

You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, leucemie aigue, updated leucemle deleted. Personal information regarding our website’s visitors, including their leucemie aigue, is confidential.

Orphanet: Leucemie aigue myeloide

Its aogue may be difficult because of associated myelofibrosis. You can move this window leucemie aigue clicking on the headline. Access to the full text of this article requires a subscription. Diagnosis of AML also relies on bone marrow aspirate or biopsy after the disease has been suspected. Pathogenesis of AML is still unclear but a two-hit model has leucemie aigue suggested as the probable mechanism for leukemogenesis.

Specialised Social Services Eurordis directory. Leucemie aigue per the Law relating to information storage and personal integrity, you have the right to oppose art 26 of that lawaccess art 34 of that law and rectify art 36 of that law your personal data. Differential leucemie aigue Differential diagnosis includes megaloblastic anaemia, myelodysplastic syndromes, acute lymphoblastic leukemia, acute biphenotypic leukemia, chronic myeloid leukemia myeloid blast phaseand keucemie of tumors such rhabdomyosarcoma and neuroblastoma see these terms.

We report the case of a 7-month-old child who presented hepatomegaly with bicytopenia. Presence of all these features leucmie not compulsory. Testes are usually not affected.

Case series

Extramedullary accumulation of myeloid blasts in different tissues, mainly skin, can be observed and is known as myeloid sarcoma see this term. She also developed bone and joint pain with recurrent aseptic arthritis.

Diagnostic methods Diagnosis relies on leucemie aigue findings showing anemia, thrombocytopenia and leucopenia or leukocytosis which result from disturbed hematopoietic function leucemie aigue to bone marrow and peripheral blood infiltration by iague blast cells. Based on stratification, patients can be treated with chemotherapy consolidation or allogenic lecuemie stem cell transplantation HSCT.

Detailed information Article for general public Italiano Deutsch Outline Masquer leucemie aigue plan. After morphological examination, immunophenotyping of leukemic cells, cytogenetic and molecular analysis should be performed.

Access to the text HTML. Acute myeloid leukemia AML is a group of neoplasms arising from precursor cells leucemie aigue leuucemie the myeloid cell-line differentiation. Access to the PDF text. Central nervous system infiltration is uncommon and mainly related with monocytic variants. Controversy is also still in the type of cell from which AML arises.

We suggested the diagnosis of megakaryoblastic leukemia early but multiple bone marrow investigations had been processed without positive results because of sampling problems and lack of abnormal cells in the morphological, leucemie aigue, and cytogenetic examinations.

Although, AML can leucemie aigue at any age, it is typically a disease affecting elder people, usually more than 65 years.

Mareynat eF. Leucemie aigue and related texts. Paillard abE. Some drugs such as azacitidine or decitabine are available for aiggue treatment of elderly AML patients under specific circumstances.

Contact Help Who are we? Etiology Pathogenesis of AML is still unclear but a two-hit model has been suggested as the probable mechanism for leukemogenesis.

Prognosis Prognosis varies leucemie aigue according to cytogenetics, molecular findings, response to induction treatment and age, between others. Top of the page – Article Outline.

AML manifests by fever, pallor, anemia, hemorrhages and recurrent infections. AML Acute myelogenous leukemia Prevalence: The main clinical picture consists of a short time period with pallor, fatigue, fever, infections and hemorrhages. If you want to leucemie aigue to this leucemie aigue, see our rates You can purchase this item in Pay Per View: Health care resources for this disease Expert leucemie aigue Diagnostic tests Patient organisations 45 Orphan leeucemie s The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.